vs
Side-by-side financial comparison of AbbVie (ABBV) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($16.6B vs $32.6M, roughly 509.6× RxSight, Inc.). AbbVie runs the higher net margin — 10.9% vs -28.1%, a 39.0% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (10.0% vs -18.9%). AbbVie produced more free cash flow last quarter ($4.9B vs $-2.3M). Over the past eight quarters, AbbVie's revenue compounded faster (16.2% CAGR vs 5.1%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
ABBV vs RXST — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $16.6B | $32.6M |
| Net Profit | $1.8B | $-9.2M |
| Gross Margin | 72.6% | 77.5% |
| Operating Margin | 27.3% | -34.8% |
| Net Margin | 10.9% | -28.1% |
| Revenue YoY | 10.0% | -18.9% |
| Net Profit YoY | 8354.5% | -54.1% |
| EPS (diluted) | $1.02 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.6B | $32.6M | ||
| Q3 25 | $15.8B | $30.3M | ||
| Q2 25 | $15.4B | $33.6M | ||
| Q1 25 | $13.3B | $37.9M | ||
| Q4 24 | $15.1B | $40.2M | ||
| Q3 24 | $14.5B | $35.3M | ||
| Q2 24 | $14.5B | $34.9M | ||
| Q1 24 | $12.3B | $29.5M |
| Q4 25 | $1.8B | $-9.2M | ||
| Q3 25 | $186.0M | $-9.8M | ||
| Q2 25 | $938.0M | $-11.8M | ||
| Q1 25 | $1.3B | $-8.2M | ||
| Q4 24 | $-22.0M | $-5.9M | ||
| Q3 24 | $1.6B | $-6.3M | ||
| Q2 24 | $1.4B | $-6.1M | ||
| Q1 24 | $1.4B | $-9.1M |
| Q4 25 | 72.6% | 77.5% | ||
| Q3 25 | 66.4% | 79.9% | ||
| Q2 25 | 71.8% | 74.9% | ||
| Q1 25 | 70.0% | 74.8% | ||
| Q4 24 | 70.9% | 71.6% | ||
| Q3 24 | 70.9% | 71.4% | ||
| Q2 24 | 70.9% | 69.5% | ||
| Q1 24 | 66.7% | 70.1% |
| Q4 25 | 27.3% | -34.8% | ||
| Q3 25 | 12.1% | -40.1% | ||
| Q2 25 | 31.7% | -41.6% | ||
| Q1 25 | 28.0% | -28.2% | ||
| Q4 24 | -9.9% | -21.5% | ||
| Q3 24 | 26.5% | -26.1% | ||
| Q2 24 | 27.6% | -23.9% | ||
| Q1 24 | 22.7% | -36.2% |
| Q4 25 | 10.9% | -28.1% | ||
| Q3 25 | 1.2% | -32.4% | ||
| Q2 25 | 6.1% | -35.0% | ||
| Q1 25 | 9.6% | -21.6% | ||
| Q4 24 | -0.1% | -14.8% | ||
| Q3 24 | 10.8% | -17.9% | ||
| Q2 24 | 9.5% | -17.4% | ||
| Q1 24 | 11.1% | -30.8% |
| Q4 25 | $1.02 | $-0.22 | ||
| Q3 25 | $0.10 | $-0.24 | ||
| Q2 25 | $0.52 | $-0.29 | ||
| Q1 25 | $0.72 | $-0.20 | ||
| Q4 24 | $-0.03 | $-0.14 | ||
| Q3 24 | $0.88 | $-0.16 | ||
| Q2 24 | $0.77 | $-0.16 | ||
| Q1 24 | $0.77 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.3B | $228.1M |
| Total DebtLower is stronger | $58.9B | — |
| Stockholders' EquityBook value | $-3.3B | $275.7M |
| Total Assets | $134.0B | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.3B | $228.1M | ||
| Q3 25 | $5.7B | $227.5M | ||
| Q2 25 | $6.5B | $227.5M | ||
| Q1 25 | $5.2B | $229.3M | ||
| Q4 24 | $5.6B | $237.2M | ||
| Q3 24 | $7.3B | $237.1M | ||
| Q2 24 | $13.2B | $233.3M | ||
| Q1 24 | $18.1B | $125.4M |
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | — | ||
| Q1 24 | $63.8B | — |
| Q4 25 | $-3.3B | $275.7M | ||
| Q3 25 | $-2.6B | $276.0M | ||
| Q2 25 | $-183.0M | $278.0M | ||
| Q1 25 | $1.4B | $279.3M | ||
| Q4 24 | $3.3B | $281.2M | ||
| Q3 24 | $6.0B | $277.3M | ||
| Q2 24 | $6.8B | $275.2M | ||
| Q1 24 | $8.0B | $163.9M |
| Q4 25 | $134.0B | $311.8M | ||
| Q3 25 | $133.9B | $308.5M | ||
| Q2 25 | $137.2B | $309.0M | ||
| Q1 25 | $136.2B | $313.0M | ||
| Q4 24 | $135.2B | $318.6M | ||
| Q3 24 | $143.4B | $310.5M | ||
| Q2 24 | $141.9B | $305.5M | ||
| Q1 24 | $148.9B | $183.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — | ||
| Q1 24 | 7.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.2B | $-1.1M |
| Free Cash FlowOCF − Capex | $4.9B | $-2.3M |
| FCF MarginFCF / Revenue | 29.4% | -6.9% |
| Capex IntensityCapex / Revenue | 2.0% | 3.5% |
| Cash ConversionOCF / Net Profit | 2.87× | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.8B | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.2B | $-1.1M | ||
| Q3 25 | $7.0B | $-1.2M | ||
| Q2 25 | $5.2B | $-4.4M | ||
| Q1 25 | $1.6B | $-8.8M | ||
| Q4 24 | $7.0B | $-4.3M | ||
| Q3 24 | $5.4B | $650.0K | ||
| Q2 24 | $2.3B | $-4.0M | ||
| Q1 24 | $4.0B | $-9.3M |
| Q4 25 | $4.9B | $-2.3M | ||
| Q3 25 | $6.6B | $-1.8M | ||
| Q2 25 | $4.9B | $-5.9M | ||
| Q1 25 | $1.4B | $-9.4M | ||
| Q4 24 | $6.8B | $-5.1M | ||
| Q3 24 | $5.2B | $-453.0K | ||
| Q2 24 | $2.0B | $-5.5M | ||
| Q1 24 | $3.8B | $-11.3M |
| Q4 25 | 29.4% | -6.9% | ||
| Q3 25 | 42.1% | -5.8% | ||
| Q2 25 | 31.7% | -17.6% | ||
| Q1 25 | 10.5% | -24.8% | ||
| Q4 24 | 44.7% | -12.7% | ||
| Q3 24 | 35.9% | -1.3% | ||
| Q2 24 | 14.0% | -15.9% | ||
| Q1 24 | 31.3% | -38.2% |
| Q4 25 | 2.0% | 3.5% | ||
| Q3 25 | 2.4% | 1.9% | ||
| Q2 25 | 1.7% | 4.6% | ||
| Q1 25 | 1.8% | 1.5% | ||
| Q4 24 | 1.9% | 2.1% | ||
| Q3 24 | 1.7% | 3.1% | ||
| Q2 24 | 1.7% | 4.4% | ||
| Q1 24 | 1.6% | 6.7% |
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | — | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABBV
Segment breakdown not available.
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
